Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,105 | -4,480 | -22,690 | -18,431 | -14,968 |
| Depreciation Amortization | 280 | 193 | 843 | 645 | 447 |
| Accounts receivable | 89 | -133 | 111 | 51 | -50 |
| Other Working Capital | -1,860 | -1,456 | 891 | 831 | 174 |
| Other Operating Activity | 178 | 267 | 7,164 | 6,515 | 6,262 |
| Operating Cash Flow | $-7,418 | $-5,609 | $-13,681 | $-10,389 | $-8,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 190 | 190 | -617 | -608 | -361 |
| Other Investing Activity | -132 | -132 | 3,880 | -76 | 0 |
| Investing Cash Flow | $58 | $58 | $3,263 | $-684 | $-361 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 266 | 266 | N/A |
| Debt Repayment | -342 | -89 | -191 | -131 | -72 |
| Common Stock Issued | 458 | 458 | -188 | -246 | -246 |
| Other Financing Activity | 0 | 0 | -36 | -30 | -20 |
| Financing Cash Flow | $116 | $369 | $-149 | $-141 | $-338 |
| Beginning Cash Position | 10,041 | 10,041 | 20,608 | 20,608 | 20,608 |
| End Cash Position | 2,797 | 4,859 | 10,041 | 9,394 | 11,702 |
| Net Cash Flow | $-7,244 | $-5,182 | $-10,567 | $-11,214 | $-4,168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,418 | -5,609 | -13,681 | -10,389 | -8,135 |
| Capital Expenditure | N/A | N/A | -617 | -608 | -361 |
| Free Cash Flow | -7,418 | -5,609 | -14,298 | -10,997 | -8,496 |